Episode 16: A Between the Biotech Waves conversation with Abraham Heifets CEO of Atomwise
Sep 29, 2022
01:00:18
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Today we talk to Abe Heifets, CEO of Atomwise, a biotech company focusing on the utilization of AI for drug discovery. Atomwise recently (post this recording) announced a $1.2B discovery deal with Sanofi. We discuss AI, its use in drug discovery and development, recent advances and the potential sentient nature of AI. Enjoy.
Between the Biotech Waves